PURCHASE AGREEMENT Between MTM TECHNOLOGIES, INC. and PEQUOT PRIVATE EQUITY FUND III, L.P. and PEQUOT OFFSHORE PRIVATE EQUITY PARTNERS III, L.P. and CONSTELLATION VENTURE CAPITAL II, L.P. and CONSTELLATION VENTURE CAPITAL OFFSHORE II, L.P. and THE BSC...
Exhibit
10.1
Between
and
PEQUOT
PRIVATE EQUITY FUND III, L.P.
and
PEQUOT
OFFSHORE PRIVATE EQUITY PARTNERS III, L.P.
and
CONSTELLATION
VENTURE CAPITAL II, L.P.
and
CONSTELLATION
VENTURE CAPITAL OFFSHORE II, L.P.
and
THE
BSC EMPLOYEE FUND VI, L.P.
and
CVC
II PARTNERS, LLC
Dated
March 29, 2007
1.
|
Purchase
and Sale of the Series A-6 Purchased Shares and Warrants
|
2
|
|
1.1
|
Authorization
of Issuance of the Series A-6 Purchased Shares and
Warrants
|
2
|
|
1.2
|
Purchase
and Sale of Series A-6 Purchased Shares and Warrants
|
2
|
|
1.3
|
Use
of Proceeds
|
2
|
|
1.4
|
Closing
|
2
|
|
2.
|
Representations and Warranties of the Company |
3
|
|
2.1
|
Organization
and Qualification
|
3
|
|
2.2
|
Certificate
of Incorporation and Bylaws
|
3
|
|
2.3
|
Corporate
Power and Authority
|
3
|
|
2.4
|
Capitalization
|
3
|
|
2.5
|
Authorization
|
5
|
|
2.6
|
Consents
|
6
|
|
2.7
|
Brokers
or Finders
|
6
|
|
2.8
|
Offering
Exemption
|
6
|
|
2.9
|
Offering
of Purchased Shares and Warrants
|
6
|
|
2.10
|
SEC
Reports
|
6
|
|
2.11
|
Financial
Statements
|
7
|
|
2.12
|
Absence
of Conflicts
|
7
|
|
3.
|
Representations and Warranties of the Purchasers |
8
|
|
3.1
|
Organization
and Qualification
|
8
|
|
3.2
|
Power
and Authority
|
8
|
|
3.3
|
Authorization
|
8
|
|
3.4
|
Purchase
Entirely for Own Account
|
8
|
|
3.5
|
Disclosure
of Information
|
9
|
|
3.6
|
Investment
Experience
|
9
|
|
3.7
|
Accredited
Investor
|
9
|
|
3.8
|
Restricted
Securities; Legends
|
9
|
|
3.9
|
No
General Solicitation
|
10
|
|
3.10
|
Absence
of Conflicts
|
10
|
|
3.11
|
Brokers
or Finders
|
10
|
|
4.
|
Conditions of the Parties |
11
|
|
4.1
|
Conditions
of Purchasers’ Obligations at the Closing
|
11
|
|
4.2
|
Conditions
of Company’s Obligations at the Closing
|
12
|
|
5.
|
Covenants |
13
|
|
5.1
|
Financial
Statements
|
13
|
i
5.2
|
Certain
Other Reports and Information
|
14
|
|
5.3
|
Further
Information; Further Assurances
|
14
|
|
5.4
|
Notice
of Certain Events
|
14
|
|
5.5
|
Visitation;
Verification
|
15
|
|
5.6
|
Insurance
|
15
|
|
5.7
|
Payment
of Taxes and Other Potential Charges and Priority Claims
|
16
|
|
5.8
|
Preservation
of Corporate Status
|
16
|
|
5.9
|
Governmental
Approvals and Filings
|
16
|
|
5.10
|
Financial
Accounting Practices
|
16
|
|
6.
|
Indemnification |
17
|
|
6.1
|
General
Indemnification
|
17
|
|
6.2
|
Indemnification
Principles
|
17
|
|
6.3
|
Claim
Notice; Right to Defend
|
17
|
|
7.
|
Certain Definitions |
18
|
|
8.
|
Miscellaneous |
22
|
|
8.1
|
Survival
of Representations and Warranties
|
22
|
|
8.2
|
Successors
and Assigns
|
22
|
|
8.3
|
Governing
Law
|
23
|
|
8.4
|
Counterparts
|
23
|
|
8.5
|
Titles
and Subtitles
|
23
|
|
8.6
|
Notices
|
23
|
|
8.7
|
Expenses
|
23
|
|
8.8
|
Consents,
Amendments and Waivers
|
24
|
|
8.9
|
Severability
|
24
|
|
8.10
|
Entire
Agreement
|
24
|
|
8.11
|
Delays
or Omissions
|
24
|
|
8.12
|
Facsimile
Signatures
|
24
|
|
8.13
|
Other
Remedies
|
25
|
|
8.14
|
Further
Assurances
|
25
|
|
8.15
|
Exchanges;
Lost, Stolen or Mutilated Stock Certificates and Warrants
|
25
|
|
8.16
|
Certain
Waivers
|
25
|
|
8.17
|
Nasdaq
Compliance
|
26
|
|
8.18
|
Further
Assurances
|
26
|
ii
Exhibit
& Schedules List
Exhibit
A
|
-
|
Form
of Registration Rights Agreement Amendment
|
Exhibit
B
|
-
|
Form
of Certificate of Amendment
|
Exhibit
C
|
-
|
Form
of Warrant
|
Exhibit
D
|
-
|
Form
of Subordination Agreement
|
Exhibit
E
|
-
|
Pro-Forma
Capitalization Table
|
Schedule
I
|
-
|
Names
and Addresses of Purchasers
|
Schedule
II
|
-
|
Schedule
of Securities Purchased
|
THIS
PURCHASE AGREEMENT (this “Agreement”)
is
made on the 29th day of March, 2007, by and among MTM Technologies, Inc., a
New
York corporation (the “Company”),
and
the purchasers listed on Schedule
I
hereto,
each of which is herein referred to as a “Purchaser”,
and
collectively, as the “Purchasers”.
W
I T N E
S S E T H:
WHEREAS,
subject to the terms and conditions set forth herein, the Company desires to
issue and sell to the Purchasers on the Closing Date (i) 2,020,202 shares of
Series A-6 Preferred Stock (the “Series
A-6 Purchased Shares”)
and
detachable warrants to purchase up to 610,000 shares (as such amount may be
adjusted in accordance with the terms thereof) of Common Stock (each, a
“Warrant”
and,
collectively, the “Warrants”),
and
the Purchasers shall purchase the Series A-6 Purchased Shares and Warrants
from
the Company on the terms and conditions set forth herein;
WHEREAS,
pursuant to that certain Amended and Restated Shareholders’ Agreement, dated as
of August 1, 2005, as amended, among the Company, the Purchasers and certain
other shareholders of the Company (the “Shareholders’
Agreement”),
the
parties thereto agreed to the imposition of certain restrictions and obligations
on such parties including, among other things, certain transfer restrictions
of
the Company’s capital stock owned by such parties, certain co-sale and right of
first refusal rights and the agreement between such parties to vote their shares
of the Company’s capital stock to elect certain individuals to the board of
directors of the Company (the “Board
of Directors”);
WHEREAS,
subject to the terms and conditions set forth herein, the Company desires to
grant certain registration rights to the Purchasers with respect to the shares
of Common Stock issuable from time to time upon conversion of the Series A-6
Purchased Shares purchased by the Purchasers and the exercise of the Warrants
and, on or prior to the Closing Date, the Company will cause that certain
Registration Rights Agreement, dated December 10, 2004, as amended, among the
Company, the Purchasers and certain individuals named therein, to be amended
by
an amendment in substantially the form attached hereto as Exhibit
A
(the
“Registration
Rights Agreement Amendment”),
to
grant the Purchasers such registration rights;
WHEREAS,
the Independent Committee of the Board of Directors has approved the execution
and delivery of this Agreement and the transactions contemplated hereby,
including without limitation, the issuance of the Certificate of Amendment
with
respect to the Series A-6 Preferred Stock attached hereto as Exhibit
B
(the
“Certificate
of Amendment”),
the
issuance of Series A-6 Purchased Shares and the Warrants and the issuance of
any
Common Stock issuable upon conversion or exercise of the foregoing, all on
the
terms and conditions set forth below;
NOW,
THEREFORE, in consideration of the premises and agreements contained in this
Agreement, and for good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, THE PARTIES HEREBY AGREE AS
FOLLOWS:
1.
Purchase
and Sale of the Series A-6 Purchased Shares and Warrants.
1.1 Authorization
of Issuance of the Series A-6 Purchased Shares and Warrants.
Subject to the terms and conditions of this Agreement, on or prior to the
Closing Date, the Company shall have authorized the issuance and sale to the
Purchasers of (i) the Series A-6 Purchased Shares and (i) the Warrants,
substantially in the form attached hereto as Exhibit C.
1.2 Purchase
and Sale of Series A-6 Purchased Shares and Warrants.
Subject to the terms and conditions of this Agreement, each Purchaser, severally
and not jointly, agrees to purchase at the Closing, and the Company agrees
to
issue and sell to each such Purchaser at the Closing (i) the number of Series
A-6 Purchased Shares set forth opposite such Purchaser’s name under the heading
“Number
of Series A-6 Purchased Shares”
on
Schedule
II
and (ii)
Warrants for the number of shares of Common Stock set forth opposite such
Purchaser’s name under the heading “Number
of Warrant Shares”
on
Schedule
II
hereto,
in exchange for the amount set forth opposite such Purchaser’s name under the
heading “Series
A-6 Shares Purchase Price”
and
“Warrant
Purchase Price”
on
Schedule
II
hereto.
1.3 Use
of
Proceeds.
The Company agrees to use the net proceeds from the sale and issuance of the
Series A-6 Purchased Shares and the Warrants (together, the “Purchased
Securities”)
pursuant to this Agreement for working capital and other general corporate
purposes.
1.4 Closing.
The purchase and sale of the Purchased Securities shall take place at the
offices of Xxxxxx Xxxx Xxxxx Raysman & Xxxxxxx LLP, 000 Xxxxx Xxxxxx, Xxx
Xxxx, Xxx Xxxx 00000, promptly upon the satisfaction or waiver of the closing
conditions set forth in Section 4.1 and 4.2 hereto, but not later than April
3,
2007, or on such other date and at such other time as the Company and Purchasers
mutually agree in writing (which time and place are designated as the
“Closing”).
The
date of the Closing is referred to herein as the “Closing
Date.”
At
the
Closing, the Company shall deliver to each Purchaser (i) shares of Series A-6
Purchased Shares in the amount set forth opposite such Purchaser’s name under
the heading “Number
of Series A-6 Purchased Shares”
on
Schedule
II
hereto
and (ii) Warrants entitling such Purchaser to purchase the number of shares
of
Common Stock set forth opposite such Purchaser’s name under the heading
“Number
of Warrant Shares”
on
Schedule
II
hereto,
all against payment in the amounts set forth opposite such Purchaser’s name
under the heading “Series
A-6 Shares and Warrant Purchase Price”
on
Schedule
II
hereto,
by wire transfer of immediately available funds to such account as the Company
designates. The Closing shall not occur, and the Company shall have no
obligation to make such deliveries, unless the Purchasers purchase and pay
for
the aggregate number of Series A-6 Purchased Shares and the Warrants set forth
on Schedule
II
hereto.
The Company shall pay any documentary stamp or similar issue or transfer taxes
due as a result of the issuance and sale of the Series A-6 Purchased Shares
and
the Warrants.
1.5 Additional
Issuance.
2
(a) Subject
to the terms and conditions of this Agreement, the Company agrees to issue
and
sell and each of (a) Pequot Private Equity Fund III, L.P. and Pequot Offshore
Private Equity Partners III, L.P. (together, the “Pequot Purchasers”) and (b)
Constellation Venture Capital II, L.P., Constellation Venture Capital Offshore
II, L.P., The BSC Employee Fund VI, L.P. and CVC II Partners, LLC (together,
the
“Constellation Purchasers”) shall have the right, on or prior to April 10, 2007,
to purchase, additional shares of Series A-6 Preferred Stock and detachable
warrants to purchase shares of Common Stock on the same terms and conditions
as
set forth herein with respect to the Series A-6 Purchased Shares and the
Warrants (the “Additional
Series A-6 Purchased Shares and Additional Warrants”).
(b) The
Pequot Purchasers may allocate up to $1,000,000 Additional Series A-6 Purchased
Shares and Additional Warrants among themselves in such manner as the Pequot
Purchasers may agree. The Constellation Purchasers may allocate up to $1,000,000
Additional Series A-6 Purchased Shares and Additional Warrants among themselves
in such manner as the Constellation Purchasers may agree. If either the Pequot
Purchasers or the Constellation Purchasers do not purchase all of the Additional
Series A-6 Purchased Shares and Additional Warrants that they are entitled
to
purchase, the other Purchasers may purchase such Additional Series A-6 Purchased
Shares and Additional Warrants in such amounts as such Purchasers may agree.
(c) The
Purchasers may exercise the right to purchase Additional Series A-6 Purchased
Shares and Additional Warrants by giving notice to the Company, at least two
business days prior to the date of such purchase which date shall be set forth
in such notice. Such date of purchase shall be a Closing Date and the time
and
place of such purchase shall be a Closing for purposes of this Agreement. The
Additional Series A-6 Purchased Shares and Additional Warrants purchased at
such
Closing shall be deemed to be Series A-6 Purchased Shares and Warrants for
all
purposes of this Agreement. The obligations of each of the Purchasers and the
Company at such Closing shall be subject to satisfaction of the respective
conditions of the Purchasers’ obligations and the Company’s obligations, as set
forth in Section 4 hereof.
2. Representations
and Warranties of the Company.
The Company hereby represents and warrants to each Purchaser the
following:
2.1 Organization
and Qualification.
Each of the Company and the Subsidiaries is duly organized, validly existing
and
in good standing under the laws of its respective jurisdiction of incorporation
or organization and has the requisite power and authority to own, lease and
operate its assets, properties and business and to carry on its business as
it
is now being conducted or proposed to be conducted. Each of the Company and
the
Subsidiaries is duly qualified as a foreign corporation to transact business,
and is in good standing, in each jurisdiction where it owns or leases real
property or maintains employees or where the nature of its activities make
such
qualification necessary, except where such failure to qualify would not have
a
Material Adverse Effect.
2.2 Certificate
of Incorporation and Bylaws.
The Company has delivered to the Purchasers true, correct, and complete copies
of the Company’s certificate of incorporation
3
as
in
effect on the date hereof (the “Existing
Certificate”)
and
the Company’s bylaws as in effect on the date hereof (the “Bylaws”).
2.3 Corporate
Power and Authority.
The Company has all requisite corporate power and authority to execute and
deliver the Transaction Documents to which it is a party. The Company has all
requisite corporate power and authority to issue and sell the Series A-6
Purchased Shares and the Warrants to the Purchasers hereunder. The Company
has
all requisite corporate power and authority to carry out and perform its
obligations under the terms of the Transaction Documents. The Company has all
requisite corporate power and authority to sell and issue the Common Stock
issuable upon conversion of the Series A-6 Preferred Stock and the exercise
of
the Warrants (together, the “Conversion
Shares”).
The
Conversion Shares have been duly reserved for issuance and when issued will
be
duly and validly issued, fully paid and nonassessable.
2.4 Capitalization.
(a) Immediately prior to the Closing, the authorized capital stock of the
Company consists of 120,000,000, of which (i) 80,000,000 are designated as
Common Stock; and (ii) 40,000,000 are designated as Preferred Stock, of which
(A) 31,000,000 are designated as “Series A Preferred Stock” as follows:
4,200,000 are designated Series A-1 Preferred Stock of which 3,353487 are issued
and outstanding, 2,600,000 of which are designated Series A-2 Preferred Stock
of
which 2,059,999 are issued and outstanding, 7,200,000 of which are designated
Series A-3 Preferred Stock of which 3,961,536 are issued and outstanding,
9,000,000 of which are designated Series A-4 Preferred Stock of which 8,081,315
are issued and outstanding and 8,000,000 of which are designated Series A-5
Preferred Stock of which 3,169,227 are issued and outstanding Shares of the
authorized Common Stock have been reserved as follows: (i) 250,000 shares of
the
authorized Common Stock have been reserved for issuance pursuant to the exercise
of stock options granted or to be granted after the date hereof under the 1993
Stock Option Plan of the Company, (ii) 350,000 shares of the authorized Common
Stock have been reserved for issuance pursuant to the exercise of stock options
granted or to be granted after the date hereof under the 1996 Stock Option
Plan
of the Company, (iii) 250,000 shares of the authorized Common Stock have been
reserved for issuance pursuant to the exercise of stock options granted or
to be
granted after the date hereof under the 1998 Stock Option Plan of the Company,
(iv) 350,000 shares of the authorized Common Stock have been reserved for
issuance pursuant to the exercise of stock options granted or to be granted
after the date hereof under the 2000 Long-Term Performance Plan of the Company,
(v) 250,000 shares of the authorized Common Stock have been reserved for
issuance pursuant to the exercise of stock options granted or to be granted
after the date hereof under the 2002 Long-Term Performance Plan of the Company,
(vi) 4,000,000 shares of the authorized Common Stock have been reserved for
issuance pursuant to the exercise of stock options granted or to be granted
after the date hereof under the 2004 Equity Incentive Plan of the Company (the
stock options described in clauses (i) through (vi), collectively, the
“Options”), (vii) 4,200,000 shares of the authorized Common Stock have been
reserved for issuance upon conversion of the Series A-1 Preferred Stock, (viii)
2,600,000 shares of the authorized Common Stock have been reserved for issuance
upon conversion of the Series A-2 Preferred Stock, (ix) 7,200,000 shares of
the
authorized Common Stock have been reserved for issuance upon conversion of
the
Series A-3 Preferred Stock, (x) 9,000,000 shares of the authorized Common Stock
have been reserved for issuance upon conversion of the Series A-4 Preferred
Stock, (xi) 8,000,000 shares of the authorized Common Stock have been reserved
for issuance upon conversion of the Series A-5 Preferred
4
Stock,
(xii) 500,000 shares of the Common Stock have been reserved for issuance
pursuant to the exercise of the Series A-1 Warrants, (xiii) 400,000 shares
of
the authorized Common Stock have been reserved for issuance pursuant to the
exercise of the Series A-2 Warrants, (xiv) 769,232 shares of the authorized
Common Stock have been reserved for issuance pursuant to the exercise of the
Series A-3 Warrants, (xv) 1,538,461 shares of the authorized Common Stock have
been reserved for issuance pursuant to the exercise of the Series A-4 Warrants,
(xvi) 450,000 shares of the authorized Common Stock have been reserved for
issuance pursuant to the exercise of the Series A-5 Warrants, (xvii) 700,000
shares of the authorized Common Stock have been reserved for issuance pursuant
to the exercise of warrants issued to Columbia Partners, Investment Management,
(xviii) 846,513 shares of Series A-1 Preferred Stock have been reserved for
issuance as dividends with respect to the Series A-1 Preferred Stock, (xix)
540,001 shares of Series A-2 Preferred Stock have been reserved for issuance
as
dividends with respect to the Series A-2 Preferred Stock, (xxv) 3,238,464 shares
of Series A-3 Preferred Stock have been reserved for issuance as dividends
with
respect to the Series A-3 Preferred Stock, (xxi) 918,685 shares of Series A-4
Preferred Stock have been reserved for issuance as dividends with respect to
the
Series A-4 Preferred Stock, (xxii) 4,830,773 shares of Series A-5 Preferred
Stock have been reserved for issuance as dividends with respect to the Series
A-5 Preferred Stock (xxiii) 250,000 shares of authorized Common Stock have
been
reserved for issuance in connection with the Company’s acquisition of Nexl Inc.
The rights, privileges and preferences of the Series A-1 Preferred Stock, Series
A-2 Preferred Stock, Series A-3 Preferred Stock, Series A-4 Preferred Stock
and
Series A-5 Preferred Stock are as stated in the Existing Certificate. As of
the
date hereof, all issued and outstanding shares of the Company’s capital stock
are duly authorized and validly issued, are fully paid and nonassessable. Except
with respect to (i) 3,246,370 options to purchase shares of Common Stock and
385,800 restricted stock units representing the right to acquire shares of
Common Stock, in each case issued pursuant to the Company’s equity incentive
plans, (ii) 3,657,693 warrants to purchase shares of Common Stock issued to
the
Purchasers in connection with the original issuance and sale of the Series
A-1
Preferred Stock, Series A-2 Preferred Stock, Series A-3 Preferred Stock, Series
A-4 Preferred Stock and Series A-5 Preferred Stock, and (iii) 700,000 warrants
to purchase shares of Common Stock issued to Columbia Partners Investment
Management there are no options, warrants, conversion privileges, or preemptive
or other rights or agreements presently outstanding to purchase or otherwise
acquire from the Company any shares of the capital stock or other securities
of
the Company. Except for the Voting Agreement and the Shareholders Agreement,
the
Company has not entered into any agreements with any of its shareholders with
respect to the voting of capital shares of the Company and to the Knowledge
of
the Company none of its shareholders are parties to such agreements. Except
as
aforesaid and as contemplated in the Transaction Documents, the Company is
not a
party to any agreement or understanding, and to its Knowledge, no shareholders
are a party to such an agreement or understanding, that affects or relates
to
the voting or giving of written consents with respect to any security, or the
voting by a director, of the Company. Except as aforesaid, to the Company’s
Knowledge, no shareholder has granted options or other rights to any entity
(other than the Company) to purchase any shares of Common Stock or other equity
securities of the Company from such shareholder. The Company is not subject
to
any obligation (contingent or otherwise) to repurchase or otherwise to acquire
or retire any shares of its capital stock. Except with respect to the issuance
of 600,732 shares of Series A Preferred Stock on November 11, 2006 in
satisfaction of the dividend obligations under the terms of the Series A
Preferred Stock, the Company has not declared or
5
paid
any
dividend or made any other distribution of cash, stock or other property to
its
shareholders.
(b) Upon
acceptance of the Certificate of Amendment by the Secretary of State of the
State of New York the Series A-6 Preferred Stock shall be designated and shall
have all such rights, including, without limitation, voting rights as set forth
in the Certificate of Amendment.
2.5 Authorization.
The execution, delivery and performance by the Company of the Transaction
Documents, the sale, issuance and delivery of the Purchased Securities and
the
performance of all of the obligations of the Company under each of the
Transaction Documents have been authorized by the Board of Directors (or a
duly
authorized committee thereof), and, other than approvals required by the Nasdaq
Stock Market (“Nasdaq”),
no
other corporate action on the part of the Company or any Subsidiary and no
other
corporate or other approval or authorization is required on the part of the
Company, or any Person by Law or otherwise in order to make the Transaction
Documents the valid, binding and enforceable obligations (subject to (i) laws
of
general application relating to bankruptcy, insolvency, and the relief of
debtors, and (ii) rules of law governing specific performance, injunctive
relief, or other equitable remedies) of the Company. Each of the Transaction
Documents, when executed and delivered by the Company, will constitute a valid
and legally binding obligation of the Company, enforceable against the Company
in accordance with its respective terms, subject to (i) laws of general
application relating to bankruptcy, insolvency, and the relief of debtors,
and
(ii) rules of law governing specific performance, injunctive relief, or other
equitable remedies.
2.6 Consents.
Except for the consents of the majority of the holders the Company’s Series A
Preferred Stock, no consent, approval, waiver or authorization, or designation,
declaration, notification, or filing with any person or entity (governmental
or
private), on the part of the Company is required in connection with the valid
execution, delivery and performance of the Transaction Documents, the offer,
sale or issuance of the Purchased Securities or the consummation of any other
transaction contemplated hereby (other than such notifications or filings
required under applicable federal or state securities laws, if any), except
for
such consents, approvals, waivers, authorizations, designations, declarations,
notifications, or filings that will be received prior to or as of the Closing
Date.
2.7 Brokers
or Finders.
The Company has not incurred, directly or indirectly, as a result of any action
taken by the Company, any liability for brokerage or finders’ fees or agents’
commissions or any similar charges in connection with this Agreement or the
issuance of the Purchased Securities or any transaction contemplated hereby
or
thereby. The Company agrees to indemnify and hold harmless each Purchaser from
any liability for any commission or compensation in the nature of a finder’s fee
(and the costs and expenses of defending against such liability or asserted
liability) for which the Company or any of its officers, employees or
representatives is responsible.
2.8 Offering
Exemption.
Assuming the truth and accuracy of the representations and warranties contained
in Section 3, the offer and sale of the Purchased Securities as contemplated
hereby and the issuance and delivery to the Purchasers of the Purchased
Securities and the Conversion Shares, are exempt from registration under
the
6
Securities
Act of 1933, as amended (the “Securities
Act”),
and
will be registered or qualified (or exempt from registration or qualification)
under applicable state securities and “blue sky” laws, as currently in
effect.
2.9 Offering
of Purchased Shares and Warrants.
No form of general solicitation or general advertising was used by the Company
or any of its agents or representatives in connection with the offer and sale
of
the Purchased Securities. Neither the Company nor, to the Company’s Knowledge,
any agent acting on the Company’s behalf has, directly or indirectly, offered
the Purchased Securities of the Company for sale to or solicited any offers
to
buy the Purchased Securities of the Company from, or otherwise approached or
negotiated with respect thereto with any other potential purchaser.
2.10 SEC
Reports.
(a) The Company has filed all required forms, reports and documents with
the Securities and Exchange Commission (the “SEC”)
since
April 1, 2001, each of which has complied in all material respects with all
applicable requirements of the Securities and the Securities Exchange Act of
1934, as amended (the “Exchange
Act”),
and
the rules and regulations promulgated thereunder, each as in effect on the
date
such forms, reports and documents were filed.
(b) None
of
the following contains any untrue statement of a material fact or omits to
state
a material fact necessary in order to make the statements contained herein
in
light of the circumstances under which they were made not misleading: (i) this
Agreement (including, the Schedules and Exhibits attached hereto), (ii) the
Existing Certificate, (iii) the Bylaws, or (iv) the SEC Reports. There is no
fact which, to the Knowledge of the Company, has not been disclosed to the
Purchasers, which could be expected to have a Material Adverse Effect on the
ability of the Company to perform its obligations under the Existing
Certificate, the Bylaws or this Agreement.
(c) The
Company is not aware of any correspondence (other than routine communications),
action or proposed or threatened action by the SEC or Nasdaq with regard to
the
Company since April 1, 2006.
2.11 Financial
Statements.
Included in the Company’s filings with the SEC are the audited financial
statements of the Company and its Subsidiaries as at and for the years ended
March 31, 2006, 2005 and 2004 and the unaudited financial statements of the
Company and its Subsidiaries for the fiscal quarters ended June 30, September
30
and December 31, 2006 (the “Financial
Statements”).
The
Financial Statements have been prepared in accordance with GAAP and fairly
present the financial condition and operating results of the Company and its
Subsidiaries as of the date, and for the period, indicated therein, except
that
the unaudited financial statements as at and for the quarters ended June 30,
September 30 and December 31, 2006 are subject to normal year-end adjustments
and do not contain all notes required under GAAP.
2.12 Absence
of Conflicts.
The Company is not in violation of or default under any provision of its
Existing Certificate or Bylaws. The execution, delivery, and performance of,
and
compliance with this Agreement and the consummation of the transactions
contemplated hereby, have not and will not:
7
(a) violate,
conflict with or result in a breach of any provision of or constitute a default
(or an event which, with notice or lapse of time or both, would constitute
a
default), under, or result in the termination of, or accelerate the performance
required by, or result in the creation of any Lien upon any of the assets,
properties or business of the Company and the Subsidiaries under, any of the
terms, conditions or provisions of the Existing Certificate or the Bylaws,
or
any material contract of the Company (for purposes of this Section 2.12(a)
a
material contract of the Company shall be only those agreements that are
included as exhibits to the Company filings with the SEC); or
(b) violate
any judgment, ruling, order, writ, injunction, award, decree, or any Law or
regulation of any court or federal, state, county or local government or any
other governmental, regulatory or administrative agency or authority which
is
applicable to the Company or any Subsidiary or any of their assets, properties
or business, which violation would have a Material Adverse Effect.
3.
Representations
and Warranties of the Purchasers.
Each Purchaser hereby represents and warrants that:
3.1 Organization
and Qualification.
Each Purchaser is duly organized, validly existing and in good standing under
the laws of its jurisdiction of incorporation or organization and its Agreement
of Limited Partnership to carry on its business as it is now being conducted
or
proposed to be conducted.
3.2 Power
and Authority.
Each Purchaser has all requisite power and authority as a limited partnership
to
execute and deliver the Transaction Documents to which it is a party, to
purchase the Purchased Securities from the Company hereunder, and to carry
out
and perform its obligations under the terms of the Transaction
Documents.
3.3 Authorization.
The execution, delivery and performance by such Purchaser of the Transaction
Documents to which it is a party, and the performance of all of the obligations
of such Purchaser under each of such Transaction Documents have been duly and
validly authorized, and no other action, approval or authorization is required
on the part of such Purchaser or any Person by Law or otherwise in order to
make
the Transaction Documents the valid, binding and enforceable obligations
(subject to (i) laws of general application relating to bankruptcy, insolvency,
and the relief of debtors, and (ii) rules of law governing specific performance,
injunctive relief, or other equitable remedies) of such Purchaser that is a
party thereto. Each of the Transaction Documents, when executed and delivered
by
such Purchaser that is a party thereto, will constitute a valid and legally
binding obligation of such Purchaser that is a party thereto, enforceable
against such Purchaser that is a party thereto in accordance with its terms
subject to: (i) laws of general application relating to bankruptcy, insolvency,
and the relief of debtors, and (ii) rules of law governing specific performance,
injunctive relief, or other equitable remedies.
3.4 Purchase
Entirely for Own Account.
The Purchased Securities and the Conversion Shares (collectively, the
“New
Securities”)
will
be acquired for investment for such Purchaser’s own account, not as a nominee or
agent, and not with a view to the resale or distribution of any part thereof.
Such Purchaser’s principal office is listed on Exhibit
I
attached
8
hereto.
Such Purchaser is aware that the Company is issuing the New Securities pursuant
to Section 4(2) of the Securities Act and Regulation D promulgated thereunder
without complying with the registration provisions of the Securities Act or
other applicable federal or state securities laws. Such Purchaser is also aware
that the Company is relying upon, among other things, the representations and
warranties of the Purchasers contained in this Agreement for purposes of
complying with Regulation D.
3.5 Disclosure
of Information.
Such Purchaser has received and carefully reviewed all the information it
considers necessary or appropriate for deciding whether to purchase the New
Securities. Such Purchaser further represents that the Company has made
available to such Purchaser, at a reasonable time prior to the date of this
Agreement, an opportunity to (a) ask questions and receive answers from the
Company regarding the terms and conditions of the offering of the New Securities
and the business, properties and financial condition of the Company, all of
which questions (if any) have been answered to the reasonable satisfaction
of
such Purchaser, and (b) obtain additional information, all of which was
furnished by the Company to the reasonable satisfaction of such Purchaser.
The
foregoing, however, does not limit or modify the representations and warranties
of the Company in Section 2 of this Agreement or the right of the Purchasers
to
rely thereon.
3.6 Investment
Experience.
Such Purchaser acknowledges that it is able to fend for itself, can bear the
economic risk of its investment, and has such knowledge and experience in
investing in companies similar to the Company and in financial or business
matters such that it is capable of evaluating the merits and risks of the
investment in the New Securities. Such Purchaser has made the determination
to
enter into this Agreement and the other agreements contemplated hereby and
to
acquire the New Securities based upon its own independent evaluation and
assessment of the value of the Company and its present and prospective business
prospects.
3.7 Accredited
Investor.
Such Purchaser is an “accredited
investor”
within
the meaning of SEC Rule 501 of Regulation D, as presently in
effect.
3.8 Restricted
Securities; Legends.
Such Purchaser recognizes that the New Securities will not be registered under
the Securities Act or other applicable federal or state securities laws. Such
Purchaser understands that the New Securities it is purchasing are characterized
as “restricted securities” under the federal securities laws inasmuch as they
are being acquired from the Company in a transaction not involving a public
offering. Such Purchaser acknowledges that it may not to sell or transfer the
New Securities unless such New Securities are registered under the Securities
Act and under any other applicable securities laws and that certificates
evidencing the New Securities will bear the following legend or similar
legend:
THIS
SECURITY AND THE SHARES OF STOCK WHICH MAY BE PURCHASED UPON THE [EXERCISE]
[CONVERSION] OF THIS SECURITY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT
OF 1933, AS AMENDED (THE “ACT”),
AND SUCH SECURITIES MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR
HYPOTHECATED IN THE ABSENCE OF SUCH REGISTRATION AND
9
REGISTRATION
UNDER APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION THEREFROM UNDER THE
ACT
AND THE RULES AND REGULATIONS THEREUNDER AND SUCH APPLICABLE STATE SECURITIES
LAWS.
THIS
SECURITY AND THE SHARES OF STOCK WHICH MAY BE PURCHASED UPON THE [EXERCISE]
[CONVERSION] OF THIS SECURITY ARE ALSO SUBJECT TO CERTAIN RESTRICTIONS ON THE
TRANSFER THEREOF PURSUANT TO A SHAREHOLDERS AGREEMENT WITH THE
ISSUER.
3.9 No
General Solicitation.
Such Purchaser acknowledges that the New Securities were not offered to such
Purchaser means of: (a) any advertisement, article, notice or other
communication published in any newspaper, magazine or similar medium, or
broadcast over television or radio, or (b) any other form of general
solicitation or advertising.
3.10 Absence
of Conflicts.
Such Purchaser’s execution, delivery, and performance of, and compliance with
the Transaction Documents and the consummation of the transactions contemplated
hereby and thereby, have not and will not:
(a) violate,
conflict with or result in a breach of any provision of or constitute a default
(or an event which, with notice or lapse of time or both, would constitute
a
default) under, or result in the termination of, or accelerate the performance
required by, or result in the creation of any Lien upon any of the assets,
properties or business of such Purchaser under, any of the terms, conditions
or
provisions of (i) its certificate/articles of formation or organization or
any
of its other formation or organizational documents, or (ii) any material
contract to which it is a party; or
(b) violate
any judgment, ruling, order, writ, injunction, award, decree, or any Law or
regulation of any court or federal, state, county or local government or any
other governmental, regulatory or administrative agency or authority which
is
applicable to such Purchaser or any of its assets, properties or businesses,
which violation would have a Material Adverse Effect.
3.11 Brokers
or Finders.
Such Purchaser has not incurred, nor will it incur, directly or indirectly,
as a
result of any action taken by such Purchaser, any liability for brokerage or
finders’ fees or agents’ commissions or any similar charges in connection with
this Agreement or the issuance of the New Securities or any transaction
contemplated hereby or thereby. Such Purchaser agrees to indemnify and hold
the
Company harmless from any liability for any commission or compensation in the
nature of a finders’ fee (and the costs and expenses of defending against such
liability or asserted liability) for which such Purchaser, or any of its
respective officers, employees or representatives is responsible.
4.
Conditions
of the Parties.
4.1 Conditions
of Purchasers’ Obligations at the Closing.
The
obligations of each Purchaser under Section 1 of this Agreement are subject
to
the satisfaction by the Company on or before the Closing of each of the
following conditions:
10
(a) Representations
and Warranties.
The representations and warranties of the Company contained in Section 2 shall
be true and correct on and as of the Closing with the same force and effect
as
though such representations and warranties had been made on and as of the date
of the Closing except as a result of events and changes thereto that do not
result in a Material Adverse Effect (except where such representation is made
as
of a specific date, it shall be true and correct as of such date except as
a
result of events and changes thereto that do not result in a Material Adverse
Effect).
(b) Performance.
The Company shall have performed and complied with all conditions contained
in
this Agreement that are required to be performed or complied with by it on
or
before the Closing.
(c) Consents
and Approvals.
All authorizations, approvals, permits, or consents, if any, of any governmental
authority or regulatory body of the United States or of any state or any
creditor of the Company or any other Person that are required in connection
with
the lawful issuance and sale of the Purchased Securities at the Closing pursuant
to this Agreement shall be duly obtained and effective as of each the Closing
and the purchase and payment of the Purchased Securities to be purchased by
the
Purchasers at each the Closing on the terms and conditions as provided herein
shall not violate any applicable Law.
(d) Good
Standing; Qualification to do Business.
The Company shall have delivered to the Purchasers certificates of good standing
with respect to the Company dated as of a date no earlier than 15 days prior
to
the any the Closing from the jurisdiction of incorporation of the Company and
from each jurisdiction in which it has qualified to do business and evidence
of
telephone confirmation thereof as of the close of business immediately prior
to
the Closing Date.
(e) Secretary’s
Certificate.
The Company shall have delivered to the Purchasers a certificate executed by
its
Secretary dated the Closing Date certifying with respect to (i) a copy of its
Existing Certificate, the Certificate of Amendment and its Bylaws as amended
to
and in effect on the Closing Date and that the Company is not in violation
of or
default under any provision of its Existing Certificate, Certificate of
Amendment or Bylaws as of and on the Closing Date, (ii) board (or committee)
resolutions authorizing the transactions contemplated by this Agreement and
the
Transaction Documents, (iii) copies of all minutes of all meetings (or excerpts
thereof) and all actions by written consent of the shareholders of the Company
authorizing the transactions contemplated in the Transaction Documents and
(iv)
incumbency matters and such other proceedings relating to the authorization,
execution and delivery of the Transaction Documents as may be reasonably
requested by the Purchasers.
(f) Cross-Receipts
of the Purchasers.
The Company and the Purchasers shall have executed and delivered a cross-receipt
acknowledging the Company’s delivery to the Purchasers of the documents and
certificates representing the Purchased Securities issued and sold to the
Purchasers on the Closing Date to the Purchasers and the Purchasers’ payment
therefor.
11
(g) Conversion
Shares.
The Conversion Shares with respect to Purchased Securities being purchased
at
the Closing, have been duly reserved for issuance and when issued will be duly
and validly issued, fully paid and nonassessable.
(h) Listing
on Stock Exchange.
Appropriate filings shall have been made to list the Common Stock on Nasdaq,
any
other national securities exchange as identified under the Exchange Act, or
the
Nasdaq OTC Bulletin Board (or comparable substitute quotation system) as of
the
Closing and no action shall have been taken by Nasdaq or such national
securities exchange to terminate such listing prior to the Closing.
(i) Registration
Rights Agreement; etc.
The Company and each other Purchaser shall have executed the Registration Rights
Agreement Amendment.
(j) Series
A-6 Purchased Shares.
The Company shall deliver to each Purchaser its respective Series A-6 Purchased
Shares.
(k) Warrants.
The Company shall deliver to each Purchaser its respective Warrants.
(l) Charter
Amendment .
The Company shall have filed at the Closing the Certificate of
Amendment.
4.2 Conditions
of Company’s Obligations at the Closing.
The obligations of the Company to consummate the transactions contemplated
by
this Agreement are subject to the satisfaction by the Purchasers on or before
any the Closing of each of the following conditions:
(a) Representations
and Warranties.
The representations and warranties of the Purchasers contained in Section 3
shall be true and correct in all material respects on and as of the Closing
(except where another date or period of time is specifically stated herein
for a
representation or warranty and in such case such representation or warranty
shall be true and correct in all material respects on and as of such
date) with
the
same force and effect as though such representations and warranties had been
made on and as of the date of the Closing; provided, however, that
representations and warranties that contain a materiality qualification shall
be
true and correct in all respects.
(b) Performance.
The Purchasers shall have performed and complied with all conditions contained
in this Agreement that are required to be performed or complied with by it
on or
before the Closing.
(c) Consents
and Approvals.
All authorizations, approvals, or permits, if any, of any governmental authority
or regulatory body of the United States or of any state or any other Person
that
are required in connection with the lawful issuance and sale of the Purchased
Securities pursuant to this Agreement shall be duly obtained and effective
as of
the Closing and the purchase and payment of the Purchased Securities to be
purchased by the Purchasers at the Closing on the terms and conditions as
provided herein shall not violate any applicable Law.
12
(d) Cross-Receipts
of the Purchasers.
The Company and the Purchasers shall have executed and delivered a cross-receipt
acknowledging the Company’s delivery to the Purchasers of the certificates
representing the Purchased Securities issued and sold to the Purchasers on
the
Closing Date to the Purchasers and the Purchasers’ payment
therefor.
(e) Purchase
Price.
The Purchasers shall have delivered to the Company the applicable purchase
price
for the Purchased Securities being purchased on the Closing Date as provided
in
Section 1.4.
(f) Complete
Purchase.
If more than one Purchaser is purchasing Purchased Securities at any the
Closing, then each such Purchaser shall have satisfied all of the foregoing
conditions in this Section 4.3 and shall have purchased the Purchased Securities
that each such Purchaser has agreed to purchase.
(g) Consent
of Series A Preferred Stockholders.
The Consent of the Series A Preferred Stockholders required pursuant to the
Company’s Certificate of Incorporation shall have been delivered to the Company.
(h) Subordination
Agreement.
The Subordination Agreement substantially in the form attached hereto as Exhibit
D shall have been executed by the Purchasers.
5. Covenants.
So
long
as any Purchaser together with any entity affiliated with it owns at least
750,000 shares of Series A Preferred Stock (as
appropriately
adjusted for any stock splits, stock dividends, combinations, and the
like),
the
Company covenants and agrees that it will comply with each of the following
covenants.
5.1 Financial
Statements.
The Company shall furnish to each Purchaser, within five Business Days after
filing, a true and complete signed copy of its Form 10-Q as filed with the
SEC
pursuant to the Exchange Act, all in such form, and together with such other
information with respect to the business of the Company, as the Purchasers
may
request, which shall present fairly, in all material respects, the financial
position of the Company as of the end of each such period and the results of
its
operations and cash flows during such period, all in accordance with GAAP.
Annually, but not later than five Business Days after filing, the Company shall
deliver to the Purchasers (i) a true and complete signed copy of its Form 10-K
as filed with the SEC pursuant to the Exchange Act and (ii) audited financial
statements which shall present fairly, in all material respects, the financial
position of the Company as of the end of each such period and the results of
its
operations and cash flows during such period, all in accordance with GAAP and
accompanied by the unqualified report and opinion thereon of the Company’s
independent certified public accountant.
5.2 Certain
Other Reports and Information.
The Company shall deliver to the Purchasers, within 30 days of issuance, all
accountants’ management letters pertaining to, all other reports submitted by
accountants in connection with any audit of, and all other reports from outside
accountants with respect to, the Company and its Subsidiaries (and, in any
event, any
13
independent
auditors’ annual management letters, if issued, will be delivered to the
Purchasers concurrently with the financial statements referred to in Section
5.1).
5.3 Further
Information; Further Assurances.
The Company will, with reasonable promptness, provide to the Purchasers such
further assurances and additional information, reports and statements respecting
its business, operations, properties and financial condition and respecting
its
Affiliates and investments, as the Purchasers may from time to time reasonably
request. The Company shall use its reasonable commercial efforts to assist
each
Purchaser with respect to the necessary Securities Act and/or Exchange Act
filings with respect to the Purchased Securities at the cost and expense of
such
Purchaser.
5.4 Notice
of Certain Events.
Promptly upon becoming aware of any of the following, the Company shall give
the
Purchasers notice thereof, together with a written statement of a Responsible
Officer of the Company setting forth the details thereof and any action with
respect thereto taken or proposed to be taken by the Company:
(i) Any
pending action, suit, proceeding or investigation by or before any Governmental
Authority against or affecting the Company (or any such action, suit, proceeding
or investigation threatened in writing) to the extent that it would result
in a
Material Adverse Effect.
(ii) Any
material violation, breach or default by the Company or any of its Subsidiaries
of or under any agreement or instrument material to its business, assets,
properties, operations or condition, financial or otherwise (it being expressly
understood and agreed that the Company need not provide notice to the Purchasers
pursuant to this Section 5.4(ii) of the termination of any such agreement or
instrument in accordance with its terms).
(iii) (A)
Any Environmental Claim made or threatened in writing against the Company,
or
(B) the Company’s becoming aware of any past or present acts, omissions, events
or circumstances (including any Release, disposition, removal, abandonment
or
escape of any Hazardous Materials on, at, in, under, above, to, from or about
any facility or property now or previously owned, operated or leased by the
Company or any of its Subsidiaries) which could form the basis of any such
Environmental Claim, which Environmental Claim, in the case of either clause
(A)
or (B), if adversely resolved, would reasonably be expected, either individually
or in the aggregate, to have a Material Adverse Effect.
(iv) The
occurrence of any Material Adverse Effect or any deviation in or change from
the
representations, warranties or covenants of the Company in this Agreement or
in
the other Transaction Documents.
5.5 Visitation;
Verification.
The Company shall permit such Persons as the Purchasers may designate from
time
to time to visit and inspect any of the properties of the Company to examine
their respective assets, properties, offices and other facilities, and books
and
records and take copies and extracts therefrom, and access to the outside
auditors of the Company and their work papers relating thereto, in each case,
as
the Purchasers may from time to time reasonably request, and to discuss their
affairs with their directors, officers, employees and independent accountants
at
such times and as often as the Purchasers may reasonably
14
request;
provided
that (i)
any such Person shall provide at least two days’ prior advance notice to the
Company of its intention to visit or inspect any of the properties of the
Company; and (ii) all such visits or inspections shall be conducted during
the
normal business hours of the Company and without undue interference with the
conduct of the Company’s business. The Company shall reimburse the Purchasers
for reasonable out-of-pocket costs and expenses of for all inspections in any
calendar year; for all other times all such visits or inspections shall be
at
the sole cost and expense of the Purchasers. The parties hereto agree that
no
investigation by the Purchasers or their representatives shall affect or limit
the scope of the representations and warranties of the Company contained herein
or in any Transaction Document delivered pursuant hereto or limit liability
for
breach of any such representation or warranty.
The
Purchasers shall have the right to examine and verify accounts, inventory and
other properties and liabilities of the Company and its Subsidiaries from time
to time, and the Company shall cooperate with the Purchasers in such
verification. Without limitation of the foregoing, subject to limitations
required due to the nature of any classified work, contracts or customer
relationships, the Company hereby authorizes its officers, employees and
independent accountants to discuss with the Purchasers the affairs of the
Company and its Subsidiaries.
5.6 Insurance.
(a) The
Company shall, and shall cause each of its Subsidiaries to (i) maintain with
financially sound and reputable insurers insurance with respect to its
properties and business and against such liabilities, workers’ compensation,
casualties and contingencies and of such types and in such amounts as are
customary in the case of corporations engaged in the same or similar businesses
or having similar properties similarly situated and naming each Purchaser as
an
additional insured and a loss payee, (ii) furnish to the Purchasers from time
to
time upon request copies of the policies under which such insurance is issued,
original certificates of insurance and such other information relating to such
insurance as the Purchasers may reasonably request, and (iii) provide such
other
insurance and endorsements as are required by this Agreement and the other
Transaction Documents.
(b) The
Company shall maintain in effect an errors and omissions insurance policy for
the Company and its Subsidiaries with (i) coverage extending to all officers
and
directors of the Company, (ii) policy limits not less than those maintained
by
the Company and its Subsidiaries on the date hereof, and (iii) deductibles
not
greater than those as are reasonable for companies engaged in the same or
similar businesses and similarly situated.
5.7 Payment
of Taxes and Other Potential Charges and Priority Claims.
The Company shall, and shall cause each of its Subsidiaries to, pay or
discharge:
(i) on
or
prior to the date on which material penalties attach thereto, all taxes,
assessments and other governmental charges imposed upon it or any of its
properties;
(ii) on
or
prior to the date when due, all lawful claims of materialmen, mechanics,
carriers, warehousemen, landlords and other like Persons which, if unpaid,
might
result in the creation of a material Lien upon any such property;
and
15
(iii) on
or
prior to the date when due, all other lawful claims which, if unpaid, might
result in the creation of a Lien upon any such property or which, if unpaid,
might give rise to a claim entitled to priority over general creditors of the
Company in a case under Title 11 (Bankruptcy) of the United States Code, as
amended;
provided
that
unless and until foreclosure, distraint, levy, sale or similar proceedings
shall
have been commenced it need not pay or discharge any such tax, assessment,
charge or claim so long as (x) the validity thereof is contested in good faith
and by appropriate proceedings diligently conducted, and (y) such reserves
or
other appropriate provisions as may be required by GAAP shall have been made
therefor.
5.8 Preservation
of Corporate Status.
The Company shall maintain its status as a corporation or other entity duly
organized, validly existing and in good standing under the laws of its
jurisdiction of incorporation or formation, and to be duly qualified to do
business as a foreign entity and in good standing in all jurisdictions in which
the ownership of its properties or the nature of its business or both make
such
qualification necessary.
5.9 Governmental
Approvals and Filings.
The Company shall obtain, keep and maintain in full force and effect all
Governmental Approvals necessary in connection with or to facilitate the
execution and delivery of this Agreement or any other Transaction Document,
consummation of the transactions herein or therein contemplated, performance
of
or compliance with the terms and conditions hereof or thereof or to ensure
the
legality, validity, binding effect, enforceability or admissibility in evidence
hereof or thereof.
5.10 Financial
Accounting Practices.
The Company shall, and shall cause each of its Subsidiaries to, make and keep
books, records and accounts which, in reasonable detail, accurately and fairly
reflect its transactions and dispositions of its assets and maintain systems
of
internal accounting controls sufficient to provide reasonable assurances that
(a) transactions are executed in accordance with management’s general or
specific authorization, (b) transactions are recorded as necessary (i) to permit
preparation of financial statements in conformity with GAAP and (ii) to maintain
accountability for assets, (c) access to assets is permitted only in accordance
with management’s general or specific authorization and (d) the recorded
accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any
differences.
6. Indemnification.
6.1 General
Indemnification.
The Company shall indemnify, defend and hold each Purchaser, its affiliates
and
their respective officers, directors, partners (general and limited), employees,
agents, attorneys successors and assigns (each a “Purchaser
Entity”)
harmless from and against all Losses incurred or suffered by a Purchaser Entity
as a result of the breach of any of the representations, warranties, covenants
or agreements made by the Company in this Agreement or any of the other
Transaction Documents, except to the extent that such Losses are the result
of
the gross negligence, willful misconduct or fraud of such Purchaser Entity.
Each
Purchaser, severally and not jointly, shall indemnify, defend and hold the
Company, its affiliates, their respective officers, directors, employees,
agents, attorneys, successors and assigns (each a “Company
Entity”)
harmless against all Losses as a result of the
16
breach
of
any of the representations, warranties, covenants or agreements made by such
Purchaser in this Agreement or any of the other Transaction Documents, except
to
the extent that such Losses are a result of the gross negligence, willful
misconduct or fraud of such Company Entity.
6.2 Indemnification
Principles.
For purposes of this Section 6, “Losses”
shall
mean each and all of the following items: claims, losses (including, without
limitation, losses of earnings), liabilities, obligations, payments, damages
(actual, punitive or consequential to the extent provided in this Section 6.2),
charges, judgments, fines, penalties, amounts paid in settlement, costs and
expenses (including, without limitation, interest which may be imposed in
connection therewith, costs and expenses of investigation, actions, suits,
proceedings, demands, assessments and reasonable fees, expenses and
disbursements of counsel, consultants and other experts). Each
Purchaser and the Company hereby agree that Losses shall not include punitive
or
consequential damages except to the extent that such Losses are the result
of
the gross negligence, willful misconduct or fraud of the party from whom the
indemnification is being sought (the “Indemnifying
Party”).
6.3 Claim
Notice; Right to Defend.
A
party seeking indemnification (the “Indemnified
Party”)
under
this Section 6 shall promptly upon becoming aware of the facts indicating that
a
claim for indemnification may be warranted, give to the Indemnifying Party
a
claim notice relating to such Loss (a “Claim
Notice”).
Each
Claim Notice shall specify the nature of the claim, the applicable provision(s)
of this Agreement or other instrument under which the claim for indemnity
arises, and, if possible, the amount or the estimated amount thereof. No failure
or delay in giving a Claim Notice (so long as the same is given prior to
expiration of the representation or warranty upon which the claim is based)
and
no failure to include any specific information relating to the claim (such
as
the amount or estimated amount thereof) or any reference to any provision of
this Agreement or other instrument under which the claim arises shall affect
the
obligation of the Indemnifying Party unless such failure materially and
adversely prejudices the Indemnifying Party. If such Loss relates to the
commencement of any action or proceeding by a third person, the Indemnified
Party shall give a Claim Notice to the Indemnifying Party regarding such action
or proceeding and the Indemnifying Party shall be entitled to participate
therein to assume the defense thereof with counsel reasonably satisfactory
to
the Indemnified Party. After the delivery of notice from the Indemnifying Party
to the Indemnified Party of its election to assume the defense of such action
or
proceeding, the Indemnifying Party shall not be liable (except to the extent
the
proviso to this sentence is applicable, in which event it will be so liable)
to
the Indemnified Party under this Section 8 for any legal or other expenses
subsequently incurred by the Indemnified Party in connection with the defense
thereof other than reasonable costs of investigation, provided
that
each Indemnified Party shall have the right to employ separate counsel to
represent it and assume its defense (in which case, the Indemnifying Party
shall
not represent it) if (i) upon the advice of counsel, the representation of
both
parties by the same counsel would be inappropriate due to actual or potential
differing interests between them, (ii) in the event the Indemnifying Party
has
not assumed the defense thereof within 10 days of receipt of notice of such
claim or commencement of action, and in which case the fees and expenses of
one
such separate counsel shall be paid by the Indemnifying Party or (iii) if such
Indemnified Party who is a defendant in any action or proceeding which is also
brought against the Indemnifying Party reasonably shall have concluded that
there may be one or more legal defenses available to such Indemnified
Party
17
which
are
not available to the Indemnifying Party. If any Indemnified Party employs such
separate counsel it will not enter into any settlement agreement which is not
approved by the Indemnifying Party, such approval not to be unreasonably
withheld. If the Indemnifying Party so assumes the defense thereof, it may
not
agree to any settlement of any such claim or action as the result of which
any
remedy or relief, other than monetary damages for which the Indemnifying Party
shall be responsible hereunder, shall be applied to or against the Indemnified
Party, without the prior written consent of the Indemnified Party. In any action
hereunder as to which the Indemnifying Party has assumed the defense thereof
with counsel reasonably satisfactory to the Indemnified Party, the Indemnified
Party shall continue to be entitled to participate in the defense thereof,
with
counsel of its own choice, but, except as set forth above, the Indemnifying
Party shall not be obligated hereunder to reimburse the Indemnified Party for
the costs thereof.
7. Certain
Definitions.
For the purposes of this Agreement the following terms will have the following
meanings:
“Affiliate(s)”
shall
mean, with respect to any Person, any other Person directly or indirectly
controlling (including but not limited to all directors and executive officers
of such Person), controlled by, or under direct or indirect common control
with
such Person. A Person shall be deemed to control a corporation for the purposes
of this definition if such Person possesses, directly or indirectly, the power
(i) to vote 10% or more of the securities having ordinary voting power for
the
election of directors of such corporation or (ii) to direct or cause the
direction of the management and policies of such corporation, whether through
the ownership of voting securities, by contract or otherwise.
“Agreement”
shall
have the meaning ascribed to it in the preliminary paragraph.
“Approval”
shall
have the meaning ascribed to it in Section 8.8(a).
“Board
of Directors”
shall
have the meaning ascribed to it in the recitals.
“Business
Day”
shall
mean any day other than a Saturday, Sunday, public holiday under the laws of
the
State of New York or any other day on which banking institutions are authorized
to close in New York City.
“Bylaws”
shall
have the meaning ascribed to it in Section 2.2.
“Certificate
of Amendment”
shall
have the meaning ascribed to it in the recitals.
“Claim
Notice”
shall
have the meaning ascribed to it in Section 6.3.
“Closing”
shall
have the meaning ascribed to it in Section 1.4.
“Closing
Date”
shall
have the meaning ascribed to it in Section 1.4.
18
“Company”
shall
have the meaning ascribed to it in the preliminary paragraph.
“Company
Entity”
shall
have the meaning ascribed to it in Section 6.1.
“Common
Stock”
shall
mean the common stock, par value $0.01 per share, of the Company.
“Conversion
Shares”
shall
have the meaning ascribed to it in Section 2.3.
“Environmental
Claim”
shall
mean, with respect to any Person, any action, suit, proceeding, notice, claim,
complaint, demand, request for information or other communication (written
or
oral) against, of or to such Person by or from any other Person (including
any
Governmental Authority, citizens’ group or present or former employee of such
Person) alleging, asserting or claiming any actual or potential (a) violation
of
or liability under any applicable environmental Law or regulation or (b)
liability for investigatory costs, cleanup costs, governmental response costs,
natural resources damages, personal injuries, fines or penalties arising out
of,
based on or resulting from the presence, or release into the environment, of
any
Hazardous Materials at any location, whether or not owned by such
Person.
“Exchange
Act”
shall
have the meaning ascribed to it in Section 2.10.
“Existing
Certificate”
shall
have the meaning ascribed to it in Section 2.2.
“Financial
Statements”
shall
have the meaning ascribed to it in Section 2.11.
“GAAP”
shall
mean generally accepted accounting principles for financial reporting in the
United States, applied on a consistent basis.
“Governmental
Approval”
shall
mean any approval, order, consent, waiver, authorization, certificate, license,
permit or validation of, or exemption or other action by, or filing, recording
or registration with, or notice to, any Governmental Authority.
“Governmental
Authority”
shall
mean any government or political subdivision or any agency, authority, bureau,
central bank, commission, department or instrumentality of either, or any court,
tribunal, grand jury or arbitrator, in each case whether foreign or
domestic.
“Hazardous
Material(s)”
shall
mean any element, compound, substance or other material (including, without
limitation, any pollutant, contaminant, hazardous waste, hazardous substance,
chemical substance, or product) that is listed, classified or regulated pursuant
to any Environmental Law, including, without limitation, any petroleum product,
by-product or additive, asbestos, presumed asbestos-containing material,
asbestos-containing material, medical waste, chlorofluorocarbon,
hydrochlorofluorocarbon, lead-containing paint, polychlorinated biphenyls,
radioactive material or radon.
19
“Hereof”,
“hereto”,
“hereunder”
and
similar terms shall refer to this Agreement and not to any particular paragraph
or provision of this Agreement.
“Indemnified
Party”
shall
have the meaning ascribed to it in Section 6.3.
“Indemnifying
Party”
shall
have the meaning ascribed to it in Section 6.2.
“Knowledge”
shall
mean with respect to the Company, the knowledge, after diligent investigation,
of the directors, officers and senior management of the Company and of the
person or persons in such entity with responsibility for the matter with respect
to which the knowledge is applicable.
“Law”
shall
mean the Company’s certificate of incorporation, as amended, the By-laws and any
foreign, federal, state or local law, statute, rule, regulation, ordinance,
code, directive, writ, injunction, decree, judgment or order applicable to
the
Company or the Subsidiaries.
“Lien(s)”
shall
mean any mortgage, deed of trust, pledge, lien, security interest, charge or
other encumbrance or security arrangement of any nature whatsoever, including
any conditional sale or title retention arrangement, and any assignment, deposit
arrangement or lease intended as, or having the effect of, security, other
than
those which together do not have a Material Adverse Effect.
“Losses”
shall
have the meaning ascribed to it in Section 6.2.
“Lien(s)”
shall
mean any mortgage, deed of trust, pledge, lien, security interest, charge or
other encumbrance or security arrangement of any nature whatsoever, including
any conditional sale or title retention arrangement, and any assignment, deposit
arrangement or lease intended as, or having the effect of,
security.
“Material
Adverse Effect”
shall
mean an effect which is materially adverse to the business, assets, properties,
operations, results of operations or condition (financial or otherwise) of
the
Company individually or of the Company and the Subsidiaries taken as a whole
(excluding general economic conditions or acts of war or terrorism).
“Nasdaq”
shall
have the meaning ascribed to it in Section 2.5.
“New
Securities”
shall
have the meaning ascribed to it in Section 3.4.
“Options”
shall
have the meaning ascribed to it in Section 2.4.
“Person”
shall
mean an individual, corporation, limited liability company, partnership, trust,
incorporated or unincorporated organization, joint venture, joint stock company,
or a government or any agency or political subdivision thereof or other entity
of any kind.
“Purchased
Securities”
shall
have the meaning ascribed to it in Section 1.3.
20
“Purchaser(s)”
shall
have the meaning ascribed to it in the preliminary paragraph.
“Purchaser
Entity”
shall
have the meaning ascribed to it in Section 6.1.
“Registration
Rights Agreement Amendment”
shall
have the meaning ascribed to it in the recitals.
“Release”
shall
mean any past or present release, spill, leak, leaching, pumping, pouring,
emitting, emptying, discharging, injecting, escaping, disposing or
dumping.
“Responsible
Officer”
shall
mean the President, Chief Executive Officer, Vice President of Finance or Chief
Financial Officer of the Company.
“SEC”
shall
have the meaning ascribed to it in Section 2.10.
“SEC
Reports”
shall
mean the Company’s (i) Annual Report on Form 10-K for the years ended March 31,
2006, 2005, and 2004, (ii) all definitive proxy statements relating to the
Company’s meeting of shareholders (whether annual or special) held since April
1, 2006 and (iii) all other reports or registration statements filed by the
Company with the SEC since April 1, 2006.
“Securities
Act”
shall
have the meaning ascribed to it in Section 2.8.
“Series
A Preferred Stock”
shall
mean, collectively, the Series A-1 Preferred Stock, Series A-2 Preferred Stock,
Series A-3 Preferred Stock, Series A-4 Preferred Stock, Series A-5 Preferred
Stock and Series A-6 Preferred Stock, each $0.001 par value per share, of the
Company.
“Series
A-6 Preferred Stock”
shall
mean the Series A-6 Preferred Stock, $0.001 par value per share, of the
Company.
“Series
A-6 Purchased Shares”
shall
have the meaning ascribed to it in the recitals.
“Shareholders’
Agreement”
shall
have the meaning ascribed to it in the recitals.
“63%
in
Interest Purchasers”
shall
mean the Purchasers owning Purchased Securities, the original purchase price
of
which constitutes at least 63% of the amounts invested by all of the Purchasers
in all of the then outstanding Purchased Securities.
“Subsidiary(ies)”
shall
mean any other corporation, limited liability company, association, joint stock
company, joint venture or business trust of which, as of the date hereof or
hereafter, (i) more than fifty percent (50%) of the outstanding voting stock,
share capital or other equity interests is owned either directly or indirectly
by any Person or one or more of its Subsidiaries, or (ii) the management of
which is otherwise controlled, directly, or indirectly through one or more
intermediaries, or both, by any Person and/or its Subsidiaries.
21
Unless
otherwise specified to the contrary herein, Subsidiary(ies) shall refer to
the
Company’s Subsidiary(ies).
“Transaction
Document(s)”
shall
mean, collectively, this Agreement, the Purchased Securities, the Registration
Rights Agreement Amendment and all other agreements and instruments and any
other documents, certificates, instruments or agreements executed pursuant
to or
in connection with any such document or this Agreement, as such documents may
be
amended from time to time.
“Warrants”
shall
have the meaning ascribed to it in the recitals.
8. Miscellaneous.
8.1 Survival
of Representations and Warranties.
The representations and warranties of the Company and Purchasers contained
in or
made pursuant to this Agreement shall survive the execution and delivery of
this
Agreement and the other Transaction Documents until the date that is three
months following the end of the second fiscal year of the Company ending after
the Closing Date.
8.2 Successors
and Assigns.
Except as otherwise provided herein, the terms and conditions of this Agreement
shall inure to the benefit of and be binding upon the respective successors
and
assigns of the parties (including transferees of any Purchased Securities).
Nothing in this Agreement, express or implied, is intended to confer upon any
party other than the parties hereto or their respective successors and assigns
any rights, remedies, obligations, or liabilities under or by reason of this
Agreement, except as expressly provided in this Agreement. Subject to applicable
securities laws and the Shareholders’ Agreement, each Purchaser shall have the
right to assign all of the rights, title and interest of such Purchaser pursuant
to this Agreement, including, without limitation, the right to purchase the
Purchased Securities and any shares of Common Stock issuable upon conversion
or
exercise thereof, to any third party reasonably acceptable to the
Company.
8.3 Governing
Law.
This Agreement shall be governed by and construed under the laws of the State
of
New York, excluding the application of any conflicts of laws principles which
would require the application of the laws of another state.
8.4 Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall
be deemed an original, but all of which together shall constitute one and the
same instrument.
8.5 Titles
and Subtitles.
The titles and subtitles used in this Agreement are used for convenience only
and are not to be considered in construing or interpreting this Agreement.
8.6 Notices.
All notices and other communications required or permitted hereunder shall
be in
writing. Notices shall be delivered personally, via recognized overnight courier
(such as Federal Express, DHL or Airborne Express) or via certified or
registered mail. Notices may be delivered via facsimile or e-mail, provided
that
by no later than two days
22
thereafter
such notice is confirmed in writing and sent via one of the methods described
in
the previous sentence. Notices shall be addressed as follows:
(a) if
to a
Purchaser, to such Purchaser’s address set forth on Schedule I
hereto;
and
(b) if
to the
Company, to MTM Technologies, Inc., 0000 Xxxx Xxxxx Xxxx, Xxxxxxxx, Xxxxxxxxxxx
00000, Attention: General Counsel, facsimile number (000) 000-0000, or at such
other address or facsimile number as the Company shall have furnished in writing
to the Purchasers, with a copy to Xxxxxx Xxxx Xxxxx Raysman & Xxxxxxx LLP,
000 Xxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000, Attention: E. Xxx Xxxx, facsimile
number (000) 000.0000.
All
notices shall be effective upon receipt.
8.7 Expenses.
The Company shall pay all costs and expenses that it incurs with respect to
the
negotiation, execution, delivery and performance of this Agreement and the
transactions contemplated hereby. If the transactions contemplated hereby are
consummated on the Closing Date or if the Company enters into a transaction
with
another potential purchaser not affiliated with any Purchaser on substantially
the terms set forth in this Agreement, the Company shall reimburse the
Purchasers for the reasonable out-of-pocket expenses (including legal fees
and
disbursements paid to counsel to the Purchasers), which the Purchasers have
incurred with respect to the negotiation, execution, delivery and performance
of
this Agreement, the other Transaction Documents and the transactions
contemplated hereby and thereby in an amount not exceeding twenty-five thousand
dollars ($25,000).
8.8 Consents,
Amendments and Waivers.
Any term of this Agreement may be amended, and the observance of any term hereof
may be waived (either generally or in a particular instance), only with the
written consent of the 63% in Interest Purchasers and the written consent of
the
Company. Any amendment or waiver effected in accordance with this Section 8.8
shall be binding upon each of the parties hereto.
8.9 Severability.
Whenever possible, each provision of this Agreement will be interpreted in
such
manner as to be effective and valid under applicable law, but if any provision
of this Agreement is held to be invalid, illegal or unenforceable in any respect
under any applicable Law or rule in any jurisdiction, such invalidity,
illegality or unenforceability will not affect any other provision or any other
jurisdiction, but this Agreement will be reformed, construed and enforced in
such jurisdiction to the greatest extent possible to carry out the intentions
of
the parties hereto.
8.10 Entire
Agreement.
Each party hereby acknowledges that no other party or any other person or entity
has made any promises, warranties, understandings or representations whatsoever,
express or implied, not contained in the Transaction Documents and acknowledges
that it has not executed the Transaction Documents in reliance upon any such
promises, representations, understandings or warranties not contained herein
or
therein and that the Transaction Documents supersede all prior agreements and
understandings between the parties with respect thereto. There are no promises,
covenants or undertakings other than those expressly set forth or provided
for
in the Transaction Documents.
23
8.11 Delays
or Omissions.
No delay or omission to exercise any right, power or remedy accruing to any
party under this Agreement, upon any breach or default of any other party under
this Agreement, shall impair any such right, power or remedy of such
nonbreaching or nondefaulting party nor shall it be construed to be a waiver
of
any such breach or default, or an acquiescence therein, or of or in any similar
breach or default thereafter occurring; nor shall any waiver of any single
breach or default be deemed a waiver of any other breach or default theretofore
or thereafter occurring.
8.12 Facsimile
Signatures.
Any signature page delivered by a fax machine shall be binding to the same
extent as an original signature page, with regard to any agreement subject
to
the terms hereof or any amendment thereto. Any party who delivers such a
signature page agrees to deliver promptly an original counterpart to each party
to whom the faxed signature page was sent.
8.13 Other
Remedies.
In addition to those remedies specifically set forth herein and in the
Transaction Documents, if any, each party may proceed to protect and enforce
its
rights under this Agreement and the Transaction Documents either by suit in
equity and/or by action at law, including, but not limited to, an action for
damages as a result of any such breach and/or an action for specific performance
of any such covenant or agreement contained in this Agreement or in the
Transaction Documents. No right or remedy conferred upon or reserved to any
party under this Agreement or the Transaction Documents is intended to be
exclusive of any other right or remedy, and every right and remedy shall be
cumulative and in addition to every other right and remedy given under this
Agreement and the Transaction Documents or now and hereafter existing under
applicable law.
8.14 Further
Assurances.
At any time or from time to time after the Closing, the Company, on the one
hand, and the Purchasers, on the other hand, agree to cooperate with each other,
and at the request of the other party, to execute and deliver any further
instruments or documents and to take all such further action as the other party
may reasonably request in order to evidence or effectuate the consummation
of
the transactions contemplated hereby relating to the purchase contemplated
herein and to otherwise carry out the intent of the parties
hereunder.
8.15 Exchanges;
Lost, Stolen or Mutilated Stock Certificates and Warrants.
Upon surrender by any Purchaser to the Company of any stock certificate or
Warrant, the Company at its expense shall issue in exchange therefor, and
deliver to such Purchaser, a replacement stock certificate or Warrant. Upon
receipt of evidence satisfactory to the Company of the loss, theft, destruction
or mutilation of any stock certificate or Warrant and in case of any such loss,
theft or destruction, upon delivery of an indemnity agreement, satisfactory
to
the Company, or in case of any such mutilation, upon surrender and cancellation
of such stock certificate or Warrant, the Company shall issue and deliver to
such Purchaser a new stock certificate or Warrant of like tenor, in lieu of
such
lost, stolen or mutilated stock certificate or Warrant.
8.16 Certain
Waivers. To
the
extent that any Purchaser has or holds preemptive rights, such Purchaser hereby
waives any and all preemptive rights that it may have with respect to the
Purchased Securities and the issuance of any Common Stock issuable upon
conversion or exercise of the Purchased Securities pursuant to this Agreement.
24
8.17 Nasdaq
Compliance.
Article FOURTH (B)(4)(a)(v) of the Existing Certificate provides for certain
adjustments to be made to the Series A Conversion Price (as defined therein)
upon the occurrence of certain events listed therein. The Company shall not
issues any Series A-6 Preferred Shares or Warrants or common stock of the
Company pursuant to such provision without compliance with Rule 4350 of the
Nasdaq Rules, specifically, obtaining shareholder approval prior to such
issuance, if so required.
8.18 Further
Assurances.
If shareholder approval is required for any securities to be issued pursuant
to
the provisions of Article FOURTH (B)(4)(a)(v) of the Existing Certificate the
Company shall request such shareholder consent in its next annual shareholders
meeting held after such requirement arises. Such annual meeting of the Company’s
shareholders shall be held in compliance with the rules of the SEC regarding
proxies, consents and authorizations of shareholders in Section 14 of the
Exchange Act, and the rules and regulations promulgated thereunder and shall
make all appropriate filings related thereto with the SEC to give effect
thereto, and to approve the authorization and issuance of such
securities.
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]
25
IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date first
above written.
The
Company:
|
||
By:
|
||
Name:
Xxxxxxx
X. Xxxxxx
Title:
Chief
Executive Officer
|
The
Purchasers:
PEQUOT
PRIVATE EQUITY FUND III, L.P.
By: Pequot
Capital Management, Inc.,
its
Investment Manager
|
|||
By:
|
|||
Name:
Title:
|
|||
PEQUOT
OFFSHORE PRIVATE EQUITY
PARTNERS
III, L.P.
By: Pequot
Capital Management, Inc.,
its
Investment Manager
|
|||
By:
|
|||
Name:
Title:
|
The
Purchasers:
CONSTELLATION
VENTURE CAPITAL II, L.P.
By: Constellation
Ventures Management II, LLC
Its
General Partner
|
|||
By:
|
|||
Name:
Title:
|
|||
CONSTELLATION
VENTURE CAPITAL OFFSHORE II, L.P.
By: Constellation
Ventures Management II, LLC
Its
General Partner
|
|||
By:
|
|||
Name:
Title:
|
|||
THE
BSC EMPLOYEE FUND VI, L.P.
By: Constellation
Ventures Management II, LLC
Its
General Partner
|
|||
By:
|
|||
Name:
Title:
|
|||
CVC
II PARTNERS, LLC
By: The
Bear Xxxxxxx Companies Inc.
Its
Managing Member
|
|||
By:
|
|||
Name:
Title:
|
Schedule
I
Names
and Addresses of Purchasers
Pequot
Private Equity Fund III, L.P.
c/o
Pequot Capital Management, Inc.
000
Xxxxx
Xxxx Xxxx
Xxxxxxxx,
Xxxxxxxxxxx 00000
Attention:
Xxxxxx Xxxxxxxxx
Fax:
(000) 000-0000
with
a
copy to:
Xxxxx
Xxxxx
c/o
Pequot Capital Management, Inc.
000
Xxxx
00xx Xxxxxx
Xxx
Xxxx,
Xxx Xxxx 00000
Fax:
(000) 000-0000
Pequot
Offshore Private Equity Partners III, L.P.
c/o
Pequot Capital Management, Inc.
000
Xxxxx
Xxxx Xxxx
Xxxxxxxx,
Xxxxxxxxxxx 00000
Attention:
Xxxxxx Xxxxxxxxx
Fax:
(000) 000-0000
with
a
copy to:
Xxxxx
Xxxxx
c/o
Pequot Capital Management, Inc.
000
Xxxx
00xx Xxxxxx
Xxx
Xxxx,
Xxx Xxxx 00000
Fax:
(000) 000-0000
Constellation
Venture Capital II, L.P.
c/o
Constellation Ventures
000
Xxxxxxx Xxxxxx
00xx
Xxxxx
Xxx
Xxxx,
Xxx Xxxx 00000
with
a
copy to:
Schedule
I
– Page
1
Xxxxxxx
X. Xxxxx, Esq.
Xxxxxxx
Xxxxxx Xxxxxx & Dodge LLP
000
Xxxxxxxxxx Xxxxxx
Xxxxxx,
XX 00000-0000 XXX
Fax:
000.000.0000
Constellation
Venture Capital Offshore II, L.P.
c/o
Constellation Ventures
000
Xxxxxxx Xxxxxx
00xx
Xxxxx
Xxx
Xxxx,
Xxx Xxxx 00000
The
BSC
Employee Fund VI, L.P.
c/o
Constellation Ventures
000
Xxxxxxx Xxxxxx
00xx
Xxxxx
Xxx
Xxxx,
Xxx Xxxx 00000
CVC
Partners II, LLC
c/o
Constellation Ventures
000
Xxxxxxx Xxxxxx
00xx
Xxxxx
Xxx
Xxxx,
Xxx Xxxx 00000
Schedule
I
– Page
2
Schedule
II
Schedule
of Securities Purchased
NAME
OF PURCHASER
|
NUMBER
OF SERIES A-6 PURCHASED SHARES
|
NUMBER
OF WARRANT SHARES
|
SERIES
A-6 SHARES AND WARRANT PURCHASE PRICE
|
Pequot
Private Equity Fund III, L.P.
|
1,317,019
|
397,674
|
$1,955,773.22
|
Pequot
Offshore Private Equity Partners III, L.P.
|
185,657
|
56,059
|
$275,700.65
|
Constellation
Venture Capital II, L.P.
|
258,367
|
78,014
|
$383,675.00
|
Constellation
Venture Capital Offshore II, L.P.
|
137,491
|
41,515
|
$204,174.14
|
The
BSC Employee Fund VI, L.P.
|
115,216
|
34,790
|
$171,095.76
|
CVC
Partners II, LLC
|
6,452
|
1,948
|
$9,581.22
|
Totals
|
2,020,202
|
610,000
|
$3,000,000
|
Schedule
II– Page
1
EXHIBIT
A
Form
of Registration Rights Agreement Amendment
Exhibit
A
– Page
1
EXHIBIT
B
Certificate
of Amendment
Exhibit
B
– Page
1
EXHIBIT
C
Form
of Warrant
Exhibit
C
– Page
1
EXHIBIT
D
Form
of Subordination Agreement
Exhibit
D
– Page
1
EXHIBIT
E
Pro
Forma Capitalization Table
Exhibit
E
– Page
1